Search clinical trials for: Part 1 Survey Group
Total 1460 results
-
Wake Forest University Health SciencesCompletedGlioma | Astrocytoma | Ependymoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | OligodendrogliomaUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Bausch & Lomb IncorporatedCompleted
-
Bukwang PharmaceuticalActive, not recruitingParkinson Disease | DyskinesiasUnited States
-
Actimed Therapeutics LtdQuotient SciencesCompleted
-
Kanyos Bio, Inc., a wholly-owned subsidiary of...PfizerRecruitingCeliac DiseaseUnited States, Australia, New Zealand
-
Merck Sharp & Dohme LLCTerminatedAlzheimer's Disease | Amnestic Mild Cognitive Impairment | Prodromal Alzheimer's Disease
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchRecruitingAdvanced Hepatocellular CarcinomaTaiwan
-
Wake Forest University Health SciencesCompleted
-
University of PittsburghCompletedDepression | Stress | Inflammatory Bowel Diseases | Dietary Habits | Mental Health Wellness 1 | Happiness | Consciousness, Level Altered | EcstasyUnited States
-
Emory UniversityTerminatedSickle Cell DiseaseUnited States
-
Novartis PharmaceuticalsCompletedPrimary Biliary CholangitisUnited States, Germany, Russian Federation, Canada, United Kingdom, Poland
-
PfizerCompletedRheumatoid Arthritis | Healthy VolunteersUnited States
-
Chiesi Farmaceutici S.p.A.CompletedCystic Fibrosis | Non-Cystic Fibrosis BronchiectasisBelgium
-
Janssen Research & Development, LLCCompletedHealthy | Asthma | Atopic DermatitisGermany, Belgium
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Beijing Biostar Pharmaceuticals Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)Completed
-
Sun Pharma Advanced Research Company LimitedTerminatedAdvanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States, India
-
AstraZenecaAcerta Pharma, LLCCompletedBioavailability | B-cell Lymphoid CancerUnited States
-
Chiesi Farmaceutici S.p.A.TerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
UCB PharmaParexelCompleted
-
Huahui HealthCompleted
-
Tetherex Pharmaceuticals CorporationCompletedChronic Obstructive Pulmonary Disease | AsthmaUnited Kingdom
-
Daewoong Pharmaceutical Co. LTD.TerminatedMild to Moderate COVID-19Korea, Republic of
-
Axalbion SACompleted
-
GlaxoSmithKlineWithdrawn
-
iN Therapeutics Co., Ltd.RecruitingPain | Osteoarthritis | Chronic Pain | Neuropathic Pain | Post Herpetic NeuralgiaAustralia
-
Bilix Co.,Ltd.RecruitingIschemia-reperfusion InjuryAustralia
-
M.D. Anderson Cancer CenterTerminatedSkin CancerUnited States
-
Bilthoven BiologicalsSerum Institute of India Pvt. Ltd.CompletedImmune Response to Oral Polio VaccineBangladesh
-
Cellid Co., Ltd.Active, not recruitingCOVID-19 | VaccinesKorea, Republic of
-
Elpiscience Biopharma, Ltd.Active, not recruitingAdvanced Solid TumorUnited States
-
HvivoPfizerRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSmall Cell Lung CancerChina
-
Domain Therapeutics SARecruitingSolid Tumor, AdultFrance, Belgium
-
AstraZenecaCompleted
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.RecruitingCML, Chronic Phase | CML, Accelerated PhaseChina
-
Janssen Research & Development, LLCCompletedTumor or LymphomaUnited States, France, Spain
-
Kadmon Corporation, LLCQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
Sun Pharmaceutical Industries LimitedCompletedScalp PsoriasisUnited States, Australia
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
Verrica Pharmaceuticals Inc.Instat Clinical Research; HeartcoR Solutions; Myonex; Vial Health Technology, IncRecruitingCarcinoma | Skin Cancer | Basal Cell Carcinoma | Cancer of the Skin, Basal Cell | Cancer of the SkinUnited States
-
M.D. Anderson Cancer CenterWithdrawnSTI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL AmyloidosisAcute Myeloid Leukemia (AML) | Refractory T Acute Lymphoblastic LeukemiaUnited States
-
Aldeyra Therapeutics, Inc.Recruiting
-
Bial - Portela C S.A.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia
-
Melbourne HealthAnHeart Therapeutics Inc.; Walter and Eliza Hall Institute of Medical ResearchActive, not recruiting
-
Janssen Research & Development, LLCCompletedNeoplasms | Lymphoma | Adenocarcinoma | Esophagogastric JunctionJapan